Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
191.82
+3.80 (2.02%)
At close: Feb 27, 2026, 4:00 PM EST
192.00
+0.18 (0.09%)
After-hours: Feb 27, 2026, 7:37 PM EST
Biogen Stock Forecast
Stock Price Forecast
The 25 analysts that cover Biogen stock have a consensus rating of "Buy" and an average price target of $194.72, which forecasts a 1.51% increase in the stock price over the next year. The lowest target is $115 and the highest is $255.
Price Target: $194.72 (+1.51%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 8 |
| Buy | 5 | 5 | 4 | 4 | 5 | 4 |
| Hold | 16 | 14 | 13 | 11 | 13 | 14 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 25 | 23 | 22 | 24 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Initiates $185 | Hold | Initiates | $185 | -3.56% | Feb 20, 2026 |
| Wedbush | Wedbush | Hold Maintains $178 → $187 | Hold | Maintains | $178 → $187 | -2.51% | Feb 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +19.90% | Feb 9, 2026 |
| BMO Capital | BMO Capital | Hold Maintains $165 → $196 | Hold | Maintains | $165 → $196 | +2.18% | Feb 9, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $157 → $177 | Hold | Maintains | $157 → $177 | -7.73% | Feb 9, 2026 |
Financial Forecast
Revenue This Year
9.62B
from 9.89B
Decreased by -2.70%
Revenue Next Year
9.53B
from 9.62B
Decreased by -0.95%
EPS This Year
15.21
from 8.79
Increased by 73.08%
EPS Next Year
16.06
from 15.21
Increased by 5.56%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.4B | 10.7B | |||
| Avg | 9.6B | 9.5B | |||
| Low | 9.0B | 8.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.0% | 10.8% | |||
| Avg | -2.7% | -0.9% | |||
| Low | -9.1% | -11.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.98 | 19.18 | |||
| Avg | 15.21 | 16.06 | |||
| Low | 10.79 | 12.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 104.6% | 26.1% | |||
| Avg | 73.1% | 5.6% | |||
| Low | 22.8% | -19.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.